Ventral horn neuropeptides modulate the release of noradrenaline from tissue slices of rat brainstem and ventral thoracic spinal cord.
The release of endogenous noradrenaline (NA) from slices of adult rat brainstem and ventral thoracic spinal cord was investigated using a fixed-volume incubation technique and HPLC with electrochemical detection. Incubation with potassium (15-50 mM) produced a dose-related increase in basal NA release that was calcium dependent. The potassium-evoked release of NA from spinal cord or brainstem slices was potentiated according to dose by preincubation with either (a) the selective alpha 2-adrenoceptor antagonist idazoxan (10(-6)-10(-4) M) or (b) the thyrotrophin-releasing hormone (TRH) analogue RX 77368 (pGlu-His-3,3'-dimethyl ProNH2; 10(-5) and 10(-4) M). Incubation of spinal cord slices with the NA uptake inhibitor maprotiline (1 microM) enhanced the effect of idazoxan but inhibited that of RX 77368. The effects of RX 77368 and potassium alone (15 mM) on NA release from both spinal cord and brainstem slices were reduced to basal levels with tetrodotoxin (10(-7) M). Similarly, preincubation of spinal cord, but not brainstem, slices with the insect neuropeptide proctolin (10(-4) M) significantly attenuated the potassium- or RX 77368-induced release of NA, whereas substance P (3 X 10(-5) and 1 X 10(-4) M) had no effect on either tissue. These results suggest that changes in NA release in the spinal cord and brainstem may mediate some of the actions of neuropeptides in ventral spinal cord, although the peptides may not be acting directly on the noradrenergic nerve terminals in these tissues.
Department of Physiology and Pharmacology, Medical School, Queen's Medical Centre, Nottingham, England.
K C
KC
Fone
J V
JV
Johnson
A P
AP
Putland
G W
GW
Bennett
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D001933:Brain Stem / Q000378:metabolism* / Q000502:physiology; D002851:Chromatography, High Pressure Liquid; D004146:Dioxanes / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004563:Electrochemistry; D019329:Idazoxan; D008297:Male; D009479:Neuropeptides / Q000502:physiology*; D009638:Norepinephrine / Q000378:metabolism*; D009842:Oligopeptides / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D011761:Pyrrolidonecarboxylic Acid / Q000031:analogs & derivatives; D051381:Rats; D011919:Rats, Inbred Strains; D013116:Spinal Cord / Q000378:metabolism* / Q000502:physiology; D013909:Thorax; D013973:Thyrotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D004146:Dioxanes; D009479:Neuropeptides; D009842:Oligopeptides; C011536:proctolin; D013973:Thyrotropin-Releasing Hormone; C027979:L-pyroglutamyl-L-histidyl-3,3-dimethylprolinamide; D011188:Potassium; D011761:Pyrrolidonecarboxylic Acid; D009638:Norepinephrine; D019329:Idazoxan